Amidst a shortage of COVID-19 tests that has encouraged fraud and counterfeits, the FTC published guidance about how to avoid purchasing fake home test kits online. Catch up on this and counterfeit drug stories across eight states.
Read More
Recent analysis at the CDC found that fentanyl is the leading cause of death for U.S. adults ages 18-45, and fake pills are playing a prominent role: in western states, more than 13% of fentanyl deaths involved counterfeit pills. Catch up on all the news here.
Read More
Senators Cassidy and Burr and Representatives Latta and Griffith introduced new legislation to permanently classify fentanyl analogues as Schedule I substances. Temporary scheduling is currently set to expire in February 2022. Catch up on this and 24 more stories in this post.
Read More
Is there money in counterfeit cough syrup? There really is—but you can never tell what’s in fake medicine and sometimes it will kill you. Watch this week’s video to learn about a recently busted cough syrup ring in Texas.
Read More
The Sacramento Bee has been steadily covering counterfeit pills made with fentanyl since 2016, but it has also used the word “overdose” to describe fake pill deaths. PSM and a group of parents asked the paper to change their language so that the public better understands the threat.
Read More
A teenager dying in North Dakota bought down a fentanyl conspiracy ring that spanned three nations and two continents.
Watch part 5 to learn about the task force that made this investigation possible.
Read More
Associates of the Assad regime have become international suppliers of counterfeit amphetamine pills.
Read More
Drug deaths in the twelve months ending in April 2021 increased 28% over the same period the previous year. The tragic increase is fueled by fentanyl and its analogues being added to the entire spectrum of illicit drugs.
Read More
Federal authorities have indicted nine Texans who allegedly sold almost $53 million in counterfeit cough syrup over the last seven years. Learn more about this case and catch up on the rest of this week’s counterfeit medicine news.
Read More